Clin2
NCT07611552Likely a fitNot yet recruiting

Inulin supplement effects in people taking GLP-1 weight-loss drugs

Obesity & Overweight

Treatments studied

Part of Hormones & metabolism clinical trials.

This study tests whether taking inulin (a dietary fiber) alongside GLP-1 medications like Semaglutide helps improve heart health and metabolism. You'll be in the trial for 6 months while continuing your current weight-loss medication.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
600 people
Ages
18 years to 64 years
Study type
Interventional

Who can take part

  • Be overweight or obese (BMI 24+ with a weight-related condition, or BMI 28+)
  • Currently taking a GLP-1 medication (like Semaglutide, Liraglutide, or Tirzepatide) for at least 3 months and plan to continue for 6 more months
  • Between 18 and 64 years old
  • Not currently using other weight-loss drugs or planning weight-loss surgery in the next 4 months
  • Not regularly using prebiotics or probiotics (plain yogurt is okay)
  • Not allergic to inulin or similar fiber supplements

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07393360Recruiting
Muscle preservation during weight loss with GLP-1 drugs

This trial tests a special medical food to help keep muscle mass while losing weight with GLP-1 medications like liraglutide, semaglutide, or tirzepatide. It's for adults with obesity or overweight with related health issues.

Milan
NCT07409831Recruiting
Incretin drugs, diet, and exercise for weight loss

This trial tests whether combining a new type of weight-loss medication with nutrition advice and physical activity helps people with obesity lose more weight. It’s for adults who are about to start an incretin-based drug for the first time.

Québec, Quebec
NCT07050888Recruiting
Inulin supplement study for type 1 diabetes

This study tests if taking inulin, a type of fiber, can help improve blood sugar control and immune health in people with type 1 diabetes. Participants will take a daily supplement for a period of time to see if it makes a difference.

Amsterdam
NCT07209046Not yet recruiting
Probiotic for weight after stopping GLP-1 medication

This trial tests whether a probiotic supplement called UltraFlora Triplebiotic can help prevent weight gain after stopping a GLP-1 medication. If you recently stopped a GLP-1 drug, this study may help you maintain your weight.

NCT07793019Not yet recruiting· Phase 1
Weight loss and safety study in overweight adults

This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.

Beijing, Beijing Municipality
NCT07095426Recruiting
Fiber supplement study for gut and blood vessel health

This study tests whether taking a fiber supplement can improve gut health and blood vessel health in people with obesity. It may help you understand how your body responds to extra fiber.

Muncie, Indiana

Hear when a new Obesity & Overweight trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.